Episode 5: HPAPIs
Listen now
Description
Lonza experts Selene Araya and Charles Johnson discuss the manufacturing process, trends, and future of highly potent compounds (HPAPIs). They highlight Lonza's facilities and expertise in producing HPAPIs across various technologies and scales, ensuring advanced containment and addressing bioavailability challenges.
More Episodes
Peer into the future of drug development with this episode of #AViewOn Drug Bioavailability Enhancement, exploring how PBPK modeling enhances drug bioavailability and paves the way for personalized medicine. Join experts Deanna Mudie and John DiBella in this discussion on making medications safer...
Published 03/05/24
Published 03/05/24
Dive into the world of targeted capsules with Vincent Jannin from Lonza and explore how these advanced drug delivery systems are transforming patient care and offering new horizons in medicine.
Published 01/10/24